PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIB vs. BIS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIB and BIS is -0.96. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-1.0

Performance

BIB vs. BIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares UltraShort Nasdaq Biotechnology (BIS). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
591.43%
-99.60%
BIB
BIS

Key characteristics

Sharpe Ratio

BIB:

0.04

BIS:

-0.21

Sortino Ratio

BIB:

0.30

BIS:

-0.06

Omega Ratio

BIB:

1.04

BIS:

0.99

Calmar Ratio

BIB:

0.03

BIS:

-0.07

Martin Ratio

BIB:

0.15

BIS:

-0.38

Ulcer Index

BIB:

9.93%

BIS:

19.62%

Daily Std Dev

BIB:

35.51%

BIS:

35.63%

Max Drawdown

BIB:

-67.24%

BIS:

-99.77%

Current Drawdown

BIB:

-53.50%

BIS:

-99.71%

Returns By Period

In the year-to-date period, BIB achieves a -9.22% return, which is significantly lower than BIS's 4.00% return. Over the past 10 years, BIB has outperformed BIS with an annualized return of -1.34%, while BIS has yielded a comparatively lower -20.64% annualized return.


BIB

YTD

-9.22%

1M

-5.34%

6M

-12.71%

1Y

-1.44%

5Y*

-3.87%

10Y*

-1.34%

BIS

YTD

4.00%

1M

4.82%

6M

10.56%

1Y

-4.31%

5Y*

-18.28%

10Y*

-20.64%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIB vs. BIS - Expense Ratio Comparison

Both BIB and BIS have an expense ratio of 0.95%.


BIB
ProShares Ultra Nasdaq Biotechnology
Expense ratio chart for BIB: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for BIS: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%

Risk-Adjusted Performance

BIB vs. BIS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIB, currently valued at 0.04, compared to the broader market0.002.004.000.04-0.21
The chart of Sortino ratio for BIB, currently valued at 0.30, compared to the broader market-2.000.002.004.006.008.0010.000.30-0.06
The chart of Omega ratio for BIB, currently valued at 1.04, compared to the broader market0.501.001.502.002.503.001.040.99
The chart of Calmar ratio for BIB, currently valued at 0.03, compared to the broader market0.005.0010.0015.000.03-0.07
The chart of Martin ratio for BIB, currently valued at 0.15, compared to the broader market0.0020.0040.0060.0080.00100.000.15-0.38
BIB
BIS

The current BIB Sharpe Ratio is 0.04, which is higher than the BIS Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of BIB and BIS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.04
-0.21
BIB
BIS

Dividends

BIB vs. BIS - Dividend Comparison

BIB's dividend yield for the trailing twelve months is around 0.89%, less than BIS's 2.58% yield.


TTM202320222021202020192018
BIB
ProShares Ultra Nasdaq Biotechnology
0.89%0.07%0.03%0.00%0.00%0.00%0.00%
BIS
ProShares UltraShort Nasdaq Biotechnology
2.58%1.75%0.00%0.00%0.44%2.10%0.37%

Drawdowns

BIB vs. BIS - Drawdown Comparison

The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum BIS drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for BIB and BIS. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%JulyAugustSeptemberOctoberNovemberDecember
-53.50%
-99.71%
BIB
BIS

Volatility

BIB vs. BIS - Volatility Comparison

ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares UltraShort Nasdaq Biotechnology (BIS) have volatilities of 11.90% and 11.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
11.90%
11.55%
BIB
BIS
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab